Page 1 of 10
European Journal of Applied Sciences – Vol. 11, No. 1
Publication Date: January 25, 2023
DOI:10.14738/aivp.111.13693.
Rajat, J., Jefwa, J. M., & Mwafaida, J. M. (2023). Efficacy of Selected Medicinal Plants of Kaya Kauma and Kaya Tsolokero Against
Bacterial Diseases. European Journal of Applied Sciences, 11(1). 70-79.
.
Services for Science and Education – United Kingdom
Efficacy of Selected Medicinal Plants of Kaya Kauma and Kaya
Tsolokero Against Bacterial Diseases
Jolly Rajat
Pwani University, P.O. Box 195-80108, Kilifi, Kenya
Joyce Mnyazi Jefwa
Pwani University, P.O. Box 195-80108, Kilifi, Kenya
Joseph Mghalu Mwafaida
Pwani University, P.O. Box 195-80108, Kilifi, Kenya
ABSTRACT
An ethnobotanical study was carried out in the sacred Kaya forests of Kauma and
Tsolokero in Kilifi County in Kenya. Ethnobotanical data on useful and medicinal
plants was collected. Communities living around these two forests basically depend
on the diversity of flora for their livelihoods. The local herbalists use indigenous
trees and shrubs to treat a variety of diseases. These skills have been passed down
through generations. In this study, a survey was carried out in twenty-six villages
around Kaya Kauma (18) and Kaya Tsolokero (8). The population was interviewed
for knowledge on medicinal plants. More emphasis was put on the Traditional
herbal practitioners (THPs) possess more information on herbal plants, their
preparation and prescription for ailments they reportedly treat. Preliminary
reports indicated that most commonly treated ailments were caused by bacteria,
fungi and viruses in that order. Based on this, eleven (11) medicinal plants
recommended for bacteria-related ailments were selected and tested in the
laboratory to validate their efficacy against Escherichia coli and Staphylococcus
aureus. Suspensions of S. aureus and E. coli were prepared form 24h fresh colonies
and diluted to x10-7 cfu/ml where 100μl of each were plated to dry on 9cm plates
filled with King B media. A protocol adopted from the THPs was used to prepare
medicinal plant formulations from the selected plants. The plant materials were
subjected to soaking, boiling or roasting as recommended and finally formulated in
SDW at 1:1 (Wt/Vol). About 40μl of the plant formulations diluted at x10-1, x10-2 and
x10-3 and SDW as control treatment were loaded on sterile paper plugs, allowed to
air dry in a laminar flow before placing them equi-distantly at 4 cm radius on the
inoculated King B media plates. More than (64%) of tested plants suppressed the
growth of either S. aureus or E. coli while 4 (>30%) suppressed both test bacteria.
In total, 91 medicinal plants were mentioned by communities in Kaya Kauma (48)
and Tsolokero (43). THPs from the two forest commonly treated ailments caused
by bacteria, fungi and viruses in that order. The bioassay tests in this study
validated the potency of more than 75% of the recommended medicinal plants that
treated bacterial infections. Concentrations used in the study were far below what
is recommended by THPs which raises concerns of possibilities of over
prescriptions. There is need therefore to regularize and standardize products from
this fast-growing industry.
Page 2 of 10
71
Rajat, J., Jefwa, J. M., & Mwafaida, J. M. (2023). Efficacy of Selected Medicinal Plants of Kaya Kauma and Kaya Tsolokero Against Bacterial Diseases.
European Journal of Applied Sciences, 11(1). 70-79.
URL: http://dx.doi.org/10.14738/aivp.111.13693
Keywords: Kaya Forest, Indigenous medicinal plants, THPs
INTRODUCTION
Plant resources are considered the most important components of human diet [6]. In Africa,
communities have used indigenous medicinal plants for millennia to survive and maintain good
health [1]. Herbal medicine has complex combinations and interactions of herbal formulations
from assorted plants have been used successfully in traditional medicine for thousands of years
[1]. . Herbal medicinal products are still widely used by communities living in the proximity of
the forests. Medicinal products used to treat malaria, skin diseases, wounds, stomach ache,
diarrhoea, blood pressure disorders, gonorrhoea, common colds and coughs, boils, and an array
of livestock diseases have been reported from these communities [27]. However, many of the
medicinal plants used by traditional herbal practitioners (THPs) have not been well
documented, despite several challenges that threaten the sustainability of this industry. The
crude formulations, prescriptions and administration remain unique with repeated claims and
self-confessions by users and THPs alike for cure of various ailments.
Traditionally, medicinal plant formulations have been administered through oral infusions or
decoctions, steaming, smoking, rubbing, massaging and through skin incisions (Orwa et al.,
2009; Oyedemi et al., 2013). Drinking concoctions comparatively take longer to get absorbed,
work internally and rebalance the digestive system (WHO, 2002). The modern herbal medicine
owes it to Anthony Cunningham who through the Indigenous Plant Use Forum (IPUF) of 1993
created interest in commercialization of herbal medicine in the USA. This was followed by
intense ethno pharmacological studies and documentation that were driven by J. Van Staden et.
al. in 1999.
It was noted in this study that communities that have settled around the Kaya forests draw
useful plant resources for their livelihoods and for medicinal purposes to treat a variety of
ailments [27]. The THPs possess knowledge on formulations and prescription of these herbal
formulations which have sustained healthy populations in the study area. Knowledge on herbal
medicine is getting recognized by scientists’ world over and so is the role played by THPs who
are the custodians of this cultural practise [17]. Indigenous knowledge on herbal medicine lays
the foundation for scientific breakthroughs and therapeutically concepts which have
accelerated drug discovery through reverse pharmacology [8].
In this paper some of the medicinal plants described by Rajat et al (2017) are revisited and their
phytochemical profiles discussed in line with the potency they display as a source of medicinal
products for residents in the two study sites. The bioassays used in this study lay a foundation
for further bio-prospecting opportunities for indigenous medicinal products from the sacred
Kaya forests of Kilifi.
MATERIALS AND METHODS
Study Area
Two Kaya Forests, Kaya Kauma and Kaya Tsolokero in Kilifi were surveyed to establish
knowledge and skills in utilizing medicinal plants. Kaya Kauma is situated between E
03°37.103’; S 39°44.266’ and E 03°37.821’; S 39°44.200’. It is 100 ha in size at an altitude of
120m above the sea level. This is a deciduous forest that slopes into Ndzovuni river in the North
Page 3 of 10
72
European Journal of Applied Sciences (EJAS) Vol. 11, Issue 1, January-2023
Services for Science and Education – United Kingdom
with severe degradations close to the villages). Kaya Tsolokero is located in Junju. It is an
evergreen forest with 10 ha of forested land. Kaya elders guided a perimeter walk to map the
two forests. A GPS marking was taken every 10m to establish the boundaries and the villages
adjacent to these two forests.
Survey
A questionnaire survey was carried in Twenty-six (26) villages around Kaya Kauma (18) and
Kaya Tsolokero (8). The population was interviewed for knowledge on medicinal plants where
more emphasis was put on the traditional herbal practitioners (THPs) who possess more
knowledge on herbal plants, their preparation and prescription for ailments they reportedly
treat. Preliminary results indicated that the most commonly treated ailments were caused by
bacteria, fungi and viruses in that respective order. Based on the output from the indigenous
medicinal practitioners, plant species that were mentioned to treat bacterial related ailments
were selected for laboratory analyses
Selection of Pathogen and Medicinal Plant Species
Escherichia coli and Staphylococus aureus were selected as representative common pathogenic
bacteria in this evaluation. Staphylococcus aureus causes minor skin infection, bacteria derma
abscesses, pneumonia, meningitis, heart valve infections, and bone infections (Oakley et al.,
2004). Similarly, Escherichia coli causes bloody diarrhoea, stomach upsets, anaemia, urinary
tract infections and subsequently kidney failure (Silvia et al, 2011). These two pathogens
presented most of the described disease symptoms mentioned by the THPs. Escherichia coli
accession number AP001918 and S. aureus accession number AP003367 were collected from
KEMRI-Welcome trust, Kilifi, for use in this study. Eleven (11) medicinal plants that were
reported to treat bacterial related ailments. were selected for bioassays. These include; Croton
pseudopulchellus (Mnyama wa nyika), Diospyros cornii (Mkulu), Flagellaria guineensis
(Mchewa), Flueggea virosa (Mkwamba), Psilotrichum scleranthus (Chibiriti), Mildbraedia
carpinifolia (Mfundiragambi) Premna chrysoclada (Mvumo), Senna occidentalis (Mtsalafu),
Vernonia homilantha (Mlazakoma) Zanthoxylum chalybeum (Mdungu).
Preparation of Infusions
Extraction protocols adopted from those used by the traditional herbal practitioners were used
to prepare infusions from the selected plant samples. Samples were either soaked or boiled in
sterile distilled water (SDW) at a ratio 1:1 (Wt/Vol). Infusions that required soaking were
extracted in SDW at 4oC overnight. Boiled samples were extracted in SDW at a ratio of 1:2
(Wt/Vol) and allowed to simmer under low flame untill the water ratio was reduced to 1:1
(Wt/Vol). Samples that required roasting to ash were prepared by burning 100 g of plant
samples in Maffol Furnace at 450°C. The ash was then dissolved in 100ml SDW to prepae the
infusion. All the prepared infusions (Table 46) were then filter-sterilized through in 0.2μm
millipore filters under sterile conditions. The sterilized solutions were then standardized and
tested against pathogenic Eschericha coli and Staphylococus aureus in invitro trials.
Bioassays
Nutrient Agar (NA) and MacConkey Agar media were sterilized at 121°C for 15 minutes and
introduced into Petri plates under sterile conditions. Penicillin (Ampiclox) at a concentration
of 25mg/ml was used as a positive control in this trial. E. coli and S. aureus were cultured on